Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04494347 · ClinicalTrials.gov registry record · NA
Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)
A NA study of Nonvalvular Atrial Fibrillation and Severe Degenerative Mitral Regurgitation, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT04494347: Recruiting NA study of Nonvalvular Atrial Fibrillation and Severe Degenerative Mitral Regurgitation, sponsored by Mayo Clinic.
NCT04494347 is a NA study of Nonvalvular Atrial Fibrillation and Severe Degenerative Mitral Regurgitation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 109,287-participant average among 5 other Nonvalvular Atrial Fibrillation trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04494347, a NA study of Nonvalvular Atrial Fibrillation and Severe Degenerative Mitral Regurgitation, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
WATCH-TMVR (Watchman for Patients with Atrial Fibrillation Undergoing Transcatheter Mitral Valve) Clinical Trial have the main objective to assess the feasibility of combining clinically indicated MitraClip TMVR and Watchman LAAO in one setting.Mayo Clinic will be the data coordinating center for this trial, which will include up to 3 sites.
Primary Outcome
Total number of Subject's Death
Conditions Studied
Interventions
- PROCEDURE MitraClip TMVR and Watchman LAAO
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Ontario
- Ottawa Heart Institute - Ottawa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT04494347 shows while recruiting
NCT04494347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 109,287-participant average among 5 other Nonvalvular Atrial Fibrillation trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Nonvalvular Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which MitraClip TMVR and Watchman LAAO is the first listed.
NCT04494347 reports a single indexed study location in Minnesota, Ontario.
Frequently Asked Questions
What is clinical trial NCT04494347 about?
NCT04494347 is a clinical study titled "Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)". WATCH-TMVR (Watchman for Patients with Atrial Fibrillation Undergoing Transcatheter Mitral Valve) Clinical Trial have the main objective to assess the feasibility of combining clinically indicated MitraClip TMVR and Watchman LAAO in one setting.Mayo Clinic will be the data coordinating center for th...
What is the current status of trial NCT04494347?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2020-11-01. Estimated completion is 2026-01.
What conditions does trial NCT04494347 study?
This clinical trial studies the following conditions: Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation.
What interventions are being tested in trial NCT04494347?
The interventions under investigation include: MitraClip TMVR and Watchman LAAO (PROCEDURE).
Who is sponsoring clinical trial NCT04494347?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04494347 being conducted?
This trial has 2 study locations across Minnesota, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonvalvular Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The CONFORMAL Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
-
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
COMPLETED
-
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
COMPLETED
-
Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI